Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer

Illumina, Inc. and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the 100,000 Genomes Project.

Please to read the entire article.